Investing in AOA is investing in the future of women's healthcare.

Learn more about our current technologies as well as our future outlook below

Akrivis GD


A liquid biopsy diagnostic test that shows excellent results in the early diagnosis of ovarian cancer through analysis of tumor marker gangliosides.

Learn more about the future of ovarian cancer diagnosis

The Pipeline

Screenshot 2020-09-25 at 21.17.49.png

At AOA we believe that if you diagnose a problem you should help with solving the problem

Get up-to-date information about our pipeline


For all general enquiries

+1 617-903-0350

For investor relations enquiries

+1 617-903-0350